ArticleMedicina (Kaunas, Lithuania)2022

Evaluation of Remdesivir for Mildly to Moderately Ill Patients with COVID-19: A Single-Arm, Single-Center, Retrospective Study.

Motoyasu Miyazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.